Small interfering RNAs targeting the rabies virus nucleoprotein gene

Virus Research

Volumn 169, Issue 1, 2012, Pages 169-174

  Yang, Yu Jiao ^a,b   Zhao, Ping Sen ^b   Zhang, Tao ^b   Wang, Hua Lei ^b   Liang, Hong Ru ^a,b   Zhao, Li Li ^a,b   Wu, Hong Xia ^b   Wang, Tie Cheng ^b   Yang, Song Tao ^b   Xia, Xian Zhu ^b  

^a JILIN UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Nucleoprotein gene; Rabies virus; Small interfering RNA

Indexed keywords

BETA ACTIN; LIPOSOME; SMALL INTERFERING RNA; SMALL INTERFERING RNA N1227; SMALL INTERFERING RNA N473; SMALL INTERFERING RNA N580; SMALL INTERFERING RNA N783; SMALL INTERFERING RNA N796; SMALL INTERFERING RNA N799; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; EXPRESSION VECTOR; FEMALE; GENE DELIVERY SYSTEM; GENE SILENCING; GENE TARGETING; GENETIC CONSERVATION; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RABIES VIRUS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SURVIVAL; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INHIBITION; VIRUS NUCLEOPROTEIN GENE; VIRUS STRAIN; VIRUS TITRATION; WESTERN BLOTTING;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL AGENTS; CELL LINE; CRICETINAE; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; LIPOSOMES; MICE; MICE, INBRED BALB C; NUCLEOPROTEINS; RABIES; RABIES VIRUS; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; CRICETINAE; MAMMALIA; MUS; RABIES VIRUS;

EID: 84867212940     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.07.024     Document Type: Article

References (28)

1. Albertini A.A., Ruigrok R.W., Blondel D. Rabies virus transcription and replication. Advances in Virus Research 2011, 79:1-22.
2. Albertini A.A., Schoehn G., Weissenhorn W., Ruigrok R.W. Structural aspects of rabies virus replication. Cellular and Molecular Life Sciences 2008, 65(2):282-294.
3. Anesti A.M., Peeters P.J., Royaux I., Coffin R.S. Efficient delivery of RNA interference to peripheral neurons in vivo using herpes simplex virus. Nucleic Acids Research 2008, 36(14):e86.
4. Bitko V., Musiyenko A., Shulyayeva O., Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nature Medicine 2005, 11(1):50-55.
5. Boden D., Pusch O., Silbermann R., Lee F., Tucker L., Ramratnam B. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Research 2004, 32(3):1154-1158.
6. Brandao P.E., Castilho J.G., Fahl W., Carnieli P., Oliveira Rde N., Macedo C.I., Carrieri M.L., Kotait I. Short-interfering RNAs as antivirals against rabies. Brazilian Journal of Infectious Diseases 2007, 11(2):224-225.
7. DeVincenzo J., Lambkin-Williams R., Wilkinson T., Cehelsky J., Nochur S., Walsh E., Meyers R., Gollob J., Vaishnaw A. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(19):8800-8805.
8. Gupta P.K., Sonwane A.A., Singh N.K., Meshram C.D., Dahiya S.S., Pawar S.S., Gupta S.P., Chaturvedi V.K., Saini M. Intracerebral delivery of small interfering RNAs (siRNAs) using adenoviral vector protects mice against lethal peripheral rabies challenge. Virus Research 2011, 163(1):11-18.
9. Habayeb M.S., Ekstrom J.O., Hultmark D. Nora virus persistent infections are not affected by the RNAi machinery. PLoS One 2009, 4(5):e5731.
10. Hemachudha T., Sunsaneewitayakul B., Desudchit T., Suankratay C., Sittipunt C., Wacharapluesadee S., Khawplod P., Wilde H., Jackson A.C. Failure of therapeutic coma and ketamine for therapy of human rabies. Journal of Neurovirology 2006, 12(5):407-409.
11. Israsena N., Supavonwong P., Ratanasetyuth N., Khawplod P., Hemachudha T. Inhibition of rabies virus replication by multiple artificial microRNAs. Antiviral Research 2009, 84(1):76-83.
12. Kim S.M., Lee K.N., Park J.Y., Ko Y.J., Joo Y.S., Kim H.S., Park J.H. Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo. Antiviral Research 2008, 80(2):178-184.
13. Kumar P., Ban H.S., Kim S.S., Wu H., Pearson T., Greiner D.L., Laouar A., Yao J., Haridas V., Habiro K., Yang Y.G., Jeong J.H., Lee K.Y., Kim Y.H., Kim S.W., Peipp M., Fey G.H., Manjunath N., Shultz L.D., Lee S.K., Shankar P. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008, 134(4):577-586.
14. Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., Xu J., Liu Y., Zheng B.J., Woodle M.C., Zhong N., Lu P.Y. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nature Medicine 2005, 11(9):944-951.
15. Liu Y.P., von Eije K.J., Schopman N.C., Westerink J.T., ter Brake O., Haasnoot J., Berkhout B. Combinatorial RNAi against HIV-1 using extended short hairpin RNAs. Molecular Therapy 2009, 17(10):1712-1723.
16. Lupberger J., Brino L., Baumert T.F. RNAi: a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle. Journal of Hepatology 2008, 48(3):523-525.
17. McCaffrey A.P., Nakai H., Pandey K., Huang Z., Salazar F.H., Xu H., Wieland S.F., Marion P.L., Kay M.A. Inhibition of hepatitis B virus in mice by RNA interference. Nature Biotechnology 2003, 21(6):639-644.
18. Morrissey D.V., Lockridge J.A., Shaw L., Blanchard K., Jensen K., Breen W., Hartsough K., Machemer L., Radka S., Jadhav V., Vaish N., Zinnen S., Vargeese C., Bowman K., Shaffer C.S., Jeffs L.B., Judge A., MacLachlan I., Polisky B. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nature Biotechnology 2005, 23(8):1002-1007.
19. Niu X.Y., Peng Z.L., Duan W.Q., Wang H., Wang P. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. International Journal of Gynecological Cancer 2006, 16(2):743-751.
20. Pacca C.C., Severino A.A., Mondini A., Rahal P., D'Avila S.G., Cordeiro J.A., Nogueira M.C., Bronzoni R.V., Nogueira M.L. RNA interference inhibits yellow fever virus replication in vitro and in vivo. Virus Genes 2009, 38(2):224-231.
21. Padwad Y.S., Mishra K.P., Jain M., Chanda S., Karan D., Ganju L. RNA interference mediated silencing of Hsp60 gene in human monocytic myeloma cell line U937 revealed decreased dengue virus multiplication. Immunobiology 2009, 214(6):422-429.
22. Pandiri A.R., Reed W.M., Mays J.K., Fadly A.M. Influence of strain, dose of virus, and age at inoculation on subgroup J avian leukosis virus persistence, antibody response, and oncogenicity in commercial meat-type chickens. Avian Diseases 2007, 51(3):725-732.
23. Saleh M.C., Van Rij R.P., Andino R. RNA silencing in viral infections: insights from poliovirus. Virus Research 2004, 102(1):11-17.
24. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P., Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Medicine 2003, 9(3):347-351.
25. Sonwane A.A., Dahiya S.S., Saini M., Chaturvedi V.K., Singh R.P., Gupta P.K. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice. Research in Veterinary Science 2012, 93(1):498-503.
26. Willoughby R.E., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., Chusid M.J., Rupprecht C.E. Survival after treatment of rabies with induction of coma. New England Journal of Medicine 2005, 352(24):2508-2514.
27. Wunner W.H., Pallatroni C., Curtis P.J. Selection of genetic inhibitors of rabies virus. Archives of Virology 2004, 149(8):1653-1662.
28. Zhang W., Wang C.Y., Yang S.T., Qin C., Hu J.L., Xia X.Z. Inhibition of highly pathogenic avian influenza virus H5N1 replication by the small interfering RNA targeting polymerase A gene. Biochemical and Biophysical Research Communications 2009, 390(3):421-426.